Online citations, reference lists, and bibliographies.
← Back to Search

Double Liposomes: Hypoglycemic Effects Of Liposomal Insulin On Normal Rats

Ken Katayama, Y. Kato, H. Onishi, T. Nagai, Y. Machida
Published 2003 · Medicine, Chemistry

Cite This
Download PDF
Analyze on Scholarcy
Share
Abstract The biopharmaceutical characteristics of double liposomes (DLs) containing insulin were examined, and the usefulness of DLs in combination with aprotinin is discussed. Encapsulation of insulin was influenced by lipid composition, and the highest efficiency was observed with positively charged liposomes. Insulin encapsulated in liposomes, especially in DLs, was protected from enzymatic proteolysis. A portion of insulin molecules was adsorbed on the surface of the membrane when liposomes were prepared using a lipid with a positive charge and was degraded by enzymes. Remarkable hypoglycemic effects were observed after intragastric administration of DLs containing insulin at a dose of 20 IU/kg to normal male Wistar rats. The highest mean relative efficacy to administration was obtained with insulin-loading DLs containing aprotinin as a protease inhibitor. These results suggest that DLs are applicable as an oral dosage form for peptide drugs such as insulin etc., especially in combination with protease inhibitors.
This paper references
10.1016/0378-5173(92)90348-6
Novel oral microspheres of insulin with protease inhibitor protecting from enzymatic degradation
M. Morishita (1992)
10.1016/0378-5173(85)90234-0
Protection of insulin from enzymatic degradation by its association to liposomes
C. Weingarten (1985)
10.1016/0005-2736(85)90386-4
A novel method for encapsulation of macromolecules in liposomes.
R. Shew (1985)
10.1016/S0378-5173(02)00427-1
Preparation of novel double liposomes using the glass-filter method.
Ken Katayama (2002)
10.1016/0005-2736(83)90504-7
Preparation of multivesicular liposomes.
S. Kim (1983)
10.1016/0304-4165(82)90267-7
Use of liposomes to aid intestinal absorption of entrapped insulin in normal and diabetic dogs.
H. M. Patel (1982)
10.1016/0378-5173(87)90023-8
Multilamellar or multivesicular vesicles
H. Talsma (1987)
Recent trial for hypoglycemic preparations
Y. Takahashi (2000)
10.1097/00002030-199508000-00002
Encapsulation of foscarnet in liposomes modifies drug intracellular accumulation, in vitro anti‐HIV-1 activity, tissue distribution, and pharmacokinetics
N. Dusserre (1995)
10.1038/387061A0
Encapsulation of bilayer vesicles by self-assembly
S. Walker (1997)
10.1016/S0168-3659(01)00494-1
Development of non-viral vectors for systemic gene delivery.
F. Liu (2002)
10.1023/A:1007514424253
Liposomes Containing Interferon-Gamma as Adjuvant in Tumor Cell Vaccines
M. van Slooten (2004)
10.1016/S0168-3659(03)00160-3
Potentiality of double liposomes containing salmon calcitonin as an oral dosage form.
Kenji Yamabe (2003)
10.1248/YAKUSHI1947.106.5_398
Reversed-Phase High-Performance Liquid Chromatography of Peptides
H. Nakazawa (1986)
10.5650/JOS1956.34.784
Liposomes : Properties and Applications
H. Kikuchi (1985)
Liver-targeted gene transfer into a Table 2. Efficacy of oral administration of liposomal insulin as percentage of IV insulin efficacy. Treatment Efficacy relative to IV
S. H. Hwang (2001)
10.1038/sj.gt.3301510
Liver-targeted gene transfer into a human hepatoblastoma cell line and in vivo by sterylglucoside-containing cationic liposomes
S. Hwang (2001)
10.1016/0378-5173(92)90349-7
Hypoglycemic effect of novel oral microspheres of insulin with protease inhibitor in normal and diabetic rats
I. Morishita (1992)



This paper is referenced by
10.2217/17435889.2.1.85
Liposome-nanoparticle hybrids for multimodal diagnostic and therapeutic applications.
W. T. Al-Jamal (2007)
10.1016/B978-0-12-384964-9.00011-6
Parenteral Delivery of Peptides and Proteins
H. Agrawal (2011)
Developing oral formulations for protein and peptide drugs
A. Parry (2013)
10.1016/J.ADDR.2007.08.019
Current challenges in non-invasive insulin delivery systems: a comparative review.
E. Khafagy (2007)
10.2174/1381612821666150416100943
Characterization of particulate drug delivery systems for oral delivery of Peptide and protein drugs.
P. C. Christophersen (2015)
10.1080/10611860600648346
The effect of particle structure of chitosan-coated liposomes and type of chitosan on oral delivery of calcitonin
J. Thongborisute (2006)
10.1016/j.jconrel.2017.04.038
Lipophilic peptide character - What oral barriers fear the most.
O. Zupančič (2017)
10.1007/s11095-019-2653-0
Folate Conjugated Double Liposomes Bearing Prednisolone and Methotrexate for Targeting Rheumatoid Arthritis
A. Verma (2019)
10.1016/S0168-3659(03)00160-3
Potentiality of double liposomes containing salmon calcitonin as an oral dosage form.
Kenji Yamabe (2003)
Non-Invasive Insulin Delivery Systems: Challenges and Needs for Improvement
P. Shivanand (2003)
10.1007/s11095-006-0284-8
Nanotechnology: Intelligent Design to Treat Complex Disease
P. Couvreur (2006)
10.1002/DDR.10162
In vivo efficacy of a novel double liposome as an oral dosage form of salmon calcitonin
Yoshinori Ebato (2003)
10.1016/j.ijpharm.2015.07.026
Liposomes containing lipids from Sulfolobus islandicus withstand intestinal bile salts: An approach for oral drug delivery?
S. M. Jensen (2015)
Administration orale d'insuline par double encapsulation : développement du système nanoparticulaire par coacervation complexe insuline/chitosane
A. Callet (2010)
10.21007/ETD.CGHS.2008.0013
Controlled Release of Insulin and Modified Insulin from a Novel Injectable Biodegradable Gel
O. Anand (2008)
10.1517/17425247.2012.717068
Oral delivery of peptides and proteins using lipid-based drug delivery systems
P. Li (2012)
10.1016/J.EJPS.2006.05.008
Preparing and evaluating delivery systems for proteins.
L. Jorgensen (2006)
10.1016/j.addr.2016.04.001
Lipid-based nanocarriers for oral peptide delivery.
Zhigao Niu (2016)
10.3109/08982104.2012.655284
Double-Liposome – Based Dual-Drug Delivery System as Vectors for Effective Management of Peptic Ulcer
A. K. Jain (2012)
Role of protease inhibitors in Insulin therapy of Diabetes : are these beneficial ?
(2015)
10.1016/S0168-3659(03)00159-7
In vitro characteristics of liposomes and double liposomes prepared using a novel glass beads method.
Kenji Yamabe (2003)
10.1007/978-1-4419-0200-9_10
Liposome-Based Mucoadhesive Formulations for Oral Delivery of Macromolecules
P. Sriamornsak (2009)
10.1016/j.nano.2013.07.011
Biotinylated liposomes as potential carriers for the oral delivery of insulin.
X. Zhang (2014)
10.1016/j.jconrel.2008.03.001
Increase of the pharmacological and pharmacokinetic efficacy of negatively charged polypeptide recombinant hirudin in rats via parenteral route by association with cationic liposomes.
M. Meng (2008)
10.1016/j.apsb.2018.06.005
Adapting liposomes for oral drug delivery
Haisheng He (2019)
10.4333/KPS.2010.40.6.353
Preparation and Characterization of Bovine Serum Albumin-loaded Cationic Liposomes: Effect of Hydration Phase
S. Park (2010)
10.4155/tde.14.82
How to overcome the limitations of current insulin administration with new non-invasive delivery systems.
Flávia Sousa (2015)
Kosmetische Basiszusammensetzung umfassend Hüllliposomen, die wenigstens zwei Liposomen mit unterschiedlichen kosmetischen Wirkstoffen einschließen und Verfahren zur Herstellung
Karin Golz-Berner (2009)
Composition de base cosmétique comprenant des liposomes à enveloppe, lesquels comprennent au moins deux liposomes ayant des effets cosmétiques différents et procédé de fabrication
Karin Golz-Berner (2009)
10.1517/17425247.2012.735658
Liposomal delivery of proteins and peptides
Janani Swaminathan (2012)
Non invasive insulins: advanced insulin therapy over this decade
T. Rajeswari (2011)
10.1016/j.ijpharm.2011.05.061
Encapsulation enhancement and stabilization of insulin in cationic liposomes.
S. Park (2011)
See more
Semantic Scholar Logo Some data provided by SemanticScholar